As BLG has no clinical side effects shown by some other anti-AR medications such as DEX, it may have better application prospect in treatment of AR and prevention of the AR-related diseases such as nasopharyngeal cancer. The gene discussed is AR; the disease is nasopharyngeal carcinoma.